Siponimod

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 332 publications

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Journal: Drug research

Published: May 12, 2026

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

Journal: Journal of neurology

Published: March 14, 2026

Structural Characterization, Toxicity Assessment and Molecular Modeling of Forced Degradation Products of Siponimod.

Structural Characterization, Toxicity Assessment and Molecular Modeling of Forced Degradation Products of Siponimod.

Journal: International journal of molecular sciences

Published: February 15, 2026

Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models.

Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models.

Journal: Cellular and molecular neurobiology

Published: February 11, 2026

Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.

Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.

Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.

Journal: The Annals of pharmacotherapy

Published: January 03, 2026

Selective Activation of GPCRs: Molecular Dynamics Shows Siponimod Binds but Fails To Activate S1PR2, Unlike S1PR1.

Selective Activation of GPCRs: Molecular Dynamics Shows Siponimod Binds but Fails To Activate S1PR2, Unlike S1PR1.

Journal: Journal of chemical information and modeling

Published: December 04, 2025

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes.

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes.

Journal: Acta neuropathologica

Published: November 24, 2025

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Journal: Therapeutic advances in neurological disorders

Published: November 09, 2025

Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.

Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.

Journal: Frontiers in immunology

Published: October 28, 2025

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Journal: BMC neurology

Published: October 12, 2025

Showing 1-12 of 332

Last Updated: 06/30/2026